WISP1/CCN4: A Potential Target for Inhibiting Prostate Cancer Growth and Spread to Bone

Mitsuaki Ono, Colette A. Inkson, Robert Sonn, Tina M. Kilts, Luis F. de Castro, Azusa Maeda, Larry W. Fisher, Pamela G. Robey, Agnes D. Berendsen, Li Li, Nancy McCartney-Francis, Aaron C. Brown, Nigel P.S. Crawford, Alfredo Molinolo, Alka Jain, Neal S. Fedarko, Marian F. Young

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Prostate cancer (PC) is a leading cause of death in men however the factors that regulate its progression and eventual metastasis to bone remain unclear. Here we show that WISP1/CCN4 expression in prostate cancer tissues was up-regulated in early stages of the disease and, further, that it correlated with increased circulating levels of WISP1 in the sera of patients at early stages of the disease. WISP1 was also elevated in the mouse prostate cancer model TRAMP in the hypoplastic diseased tissue that develops prior to advanced carcinoma formation. When the ability of anti-WISP1 antibodies to reduce the spread of PC3-Luc cells to distant sites was tested it showed that twice weekly injections of anti-WISP1 antibodies reduced the number and overall size of distant tumors developed after intracardiac (IC) injection of PC3-Luc cells in mice. The ability of antibodies against WISP1 to inhibit growth of PC3-Luc cancer cells in mice was also evaluated and showed that twice weekly injections of anti-WISP1 antibodies reduced local tumor growth when examined in xenografts. To better understand the mechanism of action, the migration of PC3-Luc cells through membranes with or without a Matrigel™ barrier showed the cells were attracted to WISP1, and that this attraction was inhibited by treatment with anti-WISP1 antibodies. We also show the expression of WISP1 at the bone-tumor interface and in the stroma of early grade cancers suggested WISP1 expression is well placed to play roles in both fostering growth of the cancer and its spread to bone. In summary, the up-regulation of WISP1 in the early stages of cancer development coupled with its ability to inhibit spread and growth of prostate cancer cells makes it both a potential target and an accessible diagnostic marker for prostate cancer.

Original languageEnglish
Article numbere71709
JournalPloS one
Volume8
Issue number8
DOIs
Publication statusPublished - Aug 14 2013

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint Dive into the research topics of 'WISP1/CCN4: A Potential Target for Inhibiting Prostate Cancer Growth and Spread to Bone'. Together they form a unique fingerprint.

  • Cite this

    Ono, M., Inkson, C. A., Sonn, R., Kilts, T. M., de Castro, L. F., Maeda, A., Fisher, L. W., Robey, P. G., Berendsen, A. D., Li, L., McCartney-Francis, N., Brown, A. C., Crawford, N. P. S., Molinolo, A., Jain, A., Fedarko, N. S., & Young, M. F. (2013). WISP1/CCN4: A Potential Target for Inhibiting Prostate Cancer Growth and Spread to Bone. PloS one, 8(8), [e71709]. https://doi.org/10.1371/journal.pone.0071709